1. Home
  2. Labeler Index
  3. E.r. Squibb & Sons, L.l.c.
  4. 0003-2187
  5. NDC Package Code: 0003-2187-13 Orencia

NDC Package 0003-2187-13 Orencia

Abatacept Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0003-2187-13
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-USE
Product Code:
0003-2187
Proprietary Name:
Orencia
Non-Proprietary Name:
Abatacept
Substance Name:
Abatacept
Usage Information:
This medication is used to treat rheumatoid arthritis, a condition in which the body's own defense system (immune system) attacks healthy tissue. This leads to swelling in the joints, which causes pain and makes it harder to move. Abatacept works by weakening your immune system. This effect helps to slow down joint damage and reduce joint pain and swelling so you can move better. This medication is also used to treat other types of arthritis (such as juvenile idiopathic arthritis, psoriatic arthritis).
11-Digit NDC Billing Format:
00003218713
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1145929 - abatacept 125 MG in 1 ML Prefilled Syringe
  • RxCUI: 1145929 - 1 ML abatacept 125 MG/ML Prefilled Syringe
  • RxCUI: 1145929 - abatacept 125 MG per 1 ML Prefilled Syringe
  • RxCUI: 1145932 - ORENCIA 125 MG in 1 ML Prefilled Syringe
  • RxCUI: 1145932 - 1 ML abatacept 125 MG/ML Prefilled Syringe [Orencia]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    E.r. Squibb & Sons, L.l.c.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • ABATACEPT 250 mg/15mL
    • Pharmacologic Class(es):
  • Decreased Cytokine Activity - [PE] (Physiologic Effect)
  • Recombinant Fusion Proteins - [CS]
  • Selective T Cell Costimulation Modulator - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA125118
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    01-01-2009
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0003-2187-13 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00003218713J0129Abatacept injection10 MG112525

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0003-2187-101 VIAL, SINGLE-USE in 1 CELLO PACK / 15 mL in 1 VIAL, SINGLE-USE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0003-2187-13?

    The NDC Packaged Code 0003-2187-13 is assigned to a package of 1 vial, single-use in 1 carton / 15 ml in 1 vial, single-use of Orencia, a human prescription drug labeled by E.r. Squibb & Sons, L.l.c.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.

    Is NDC 0003-2187 included in the NDC Directory?

    Yes, Orencia with product code 0003-2187 is active and included in the NDC Directory. The product was first marketed by E.r. Squibb & Sons, L.l.c. on January 01, 2009 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0003-2187-13?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0003-2187-13?

    The 11-digit format is 00003218713. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20003-2187-135-4-200003-2187-13